ribavirin has been researched along with niacinamide in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (15.38) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Goldstein, BM; Li, H | 1 |
Alvarez, E; Robins, RK; Saunders, PP; Spindler, CD; Tan, MT | 1 |
Malinoski, F; Stollar, V | 1 |
Cooney, DA; Glazer, RI; Jayaram, HN; Johns, DG; Smith, AL | 1 |
Goldstein, BM; Jayaram, HN; Lesiak-Watanabe, K; Pankiewicz, KW; Watanabe, KA | 1 |
Bieganowski, P; Brenner, C | 1 |
Cappellacci, L; Cimadamore, F; Franchetti, P; Magni, G; Orsomando, G; Petrelli, R; Scotti, S; Sorci, L | 1 |
Pár, A; Pár, G | 1 |
Bhoori, S; Germini, A; Lampis, A; Mazzaferro, V; Pellegrinelli, A; Sposito, C; Toffanin, S | 1 |
Amri, A; Arguello, M; Borden, K; Cormack, G; Kraljacic, BC | 1 |
Kudo, M | 1 |
Dong, S; Han, X; Tian, Y; Wu, Y; Yang, R; Zhang, B; Zhang, Q; Zhu, S | 1 |
1 review(s) available for ribavirin and niacinamide
Article | Year |
---|---|
Adjuvant therapy after curative treatment for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemotherapy, Adjuvant; Clinical Trials as Topic; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Polyethylene Glycols; Pyridines; Recombinant Proteins; Ribavirin; Sorafenib | 2011 |
12 other study(ies) available for ribavirin and niacinamide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Carboxamide group conformation in the nicotinamide and thiazole-4-carboxamide rings: implications for enzyme binding.
Topics: Adenine Nucleotides; Amides; Antineoplastic Agents; Crystallography; Enzyme Inhibitors; IMP Dehydrogenase; Molecular Conformation; NADP; Niacinamide; Ribavirin; Stereoisomerism; Structure-Activity Relationship | 1992 |
Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells.
Topics: Adenosine Kinase; Adenosine Triphosphate; Animals; Antimetabolites, Antineoplastic; Biotransformation; Cell Line; Cricetinae; Cricetulus; Female; Inosine Monophosphate; Kinetics; Niacinamide; Ovary; Phosphorylation; Pyridinium Compounds; Ribavirin; Ribonucleosides | 1990 |
Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
Topics: Aedes; Amanitins; Animals; Cells, Cultured; Dactinomycin; Guanosine Triphosphate; IMP Dehydrogenase; Ketone Oxidoreductases; Mycophenolic Acid; Niacinamide; Phosphorylation; Ribavirin; Ribonucleosides; Sindbis Virus; Thiadiazoles; Vesicular stomatitis Indiana virus; Virus Replication | 1981 |
Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
Topics: Animals; Antineoplastic Agents; Guanosine; Hypoxanthines; IMP Dehydrogenase; Kinetics; Leukemia P388; Leukemia, Experimental; Mice; Niacinamide; Nucleic Acids; Ribavirin; Ribonucleosides; Time Factors | 1982 |
The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
Topics: Antineoplastic Agents; Cell Survival; Humans; IMP Dehydrogenase; NAD; Niacinamide; Organoselenium Compounds; Pyridinium Compounds; Ribavirin; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 2002 |
Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans.
Topics: Chromosomes, Human, Pair 9; Energy Metabolism; Evolution, Molecular; Fungi; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Fungal; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; NAD; Niacinamide; Nucleosides; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Pyridinium Compounds; Ribavirin; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid | 2004 |
Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis.
Topics: Cell Line; Cell Line, Tumor; Chlorides; Humans; Isoenzymes; Kinetics; Magnesium Chloride; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Pyridinium Compounds; Ribavirin; Substrate Specificity; Zinc Compounds | 2007 |
[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].
Topics: Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Clinical Trials as Topic; Delayed-Action Preparations; Europe; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Liver Neoplasms; Niacinamide; Oligopeptides; Patient Compliance; Phenylurea Compounds; Polyethylene Glycols; Proline; Pyridines; Recombinant Proteins; Ribavirin; Societies, Medical; Sorafenib | 2008 |
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antiviral Agents; Benzenesulfonates; beta Catenin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; DNA Mutational Analysis; Everolimus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Point Mutation; Precision Medicine; Pyridines; Ribavirin; Sirolimus; Sorafenib | 2010 |
Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Binding, Competitive; Clinical Trials, Phase II as Topic; Cytarabine; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Niacinamide; Phenylurea Compounds; Pyridines; Ribavirin; RNA Caps; Sorafenib; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2011 |
Metabolomics study of ribavirin in the treatment of orthotopic lung cancer based on UPLC-Q-TOF/MS.
Topics: Animals; Arachidonic Acid; Biomarkers; Chromatography, High Pressure Liquid; Linoleic Acid; Lung Neoplasms; Metabolomics; Mice; Niacinamide; Ribavirin; Taurine | 2023 |